Genz-10850 is an investigational drug.
There have been 9 clinical trials for Genz-10850.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2010.
The most common disease conditions in clinical trials are Gaucher Disease, Kidney Diseases, and Lipidoses. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].